Koyama H, Cecka J M, Terasaki P I
Department of Surgery, UCLA Tissue Typing Laboratory 90024.
Transplantation. 1994 Apr 15;57(7):1064-8.
Primary kidney transplants from living related and cadaveric donors to black recipients failed twice as rapidly as those to white recipients in data reported to the United Network for Organ Sharing Scientific Renal Transplant Registry between 1987 and 1991. The projected half-life for 132 HLA-identical sibling donor transplants in blacks was 15 years versus 29 years for 1,033 whites (P < 0.001). For recipients of cadaveric grafts, the half-lives were 5 years for blacks (n = 5,282) and 10 years for whites (n = 14,917). The 1-year graft survival rates and half-lives improved with HLA matching in both blacks and whites, but the 2-fold difference in long-term survival rates persisted even among recipients of well-matched grafts. With a zero HLA-A,B-mismatched donor, blacks had an 8-year half-life, compared with 17 years for whites (P < 0.001). The racial difference was most marked in young adults, with a 15-20% disparity at 3 years between blacks and whites aged 16-30. Pediatric and older black patients had 3-year graft survival rates similar to those of whites. Antilymphocyte globulin or OKT3 prophylaxis improved graft survival by 2% at 1 year and 5% at 2 years among blacks, but the half-life remained 5.6 years. In contrast to these findings in the United States, 63 blacks transplanted in Canada had the same short- and long-term graft survival as whites, suggesting an important long-term influence of the health care system and socioeconomic factors. In addition to improved access to health care and improved HLA typing of blacks, more black donors are needed to provide better matched transplants for blacks awaiting transplants.
1987年至1991年向器官共享联合网络科学肾脏移植登记处报告的数据显示,来自活体亲属和尸体供体的原发性肾脏移植给黑人受者的失败速度是给白人受者的两倍。132例黑人中HLA全相同的同胞供体移植的预计半衰期为15年,而1033例白人的为29年(P<0.001)。对于尸体移植受者,黑人(n=5282)的半衰期为5年,白人(n=14917)的为10年。黑人和白人的1年移植存活率和半衰期均随HLA配型改善而提高,但即使在配型良好的移植受者中,长期存活率的2倍差异仍然存在。对于HLA-A、B错配为零的供体,黑人的半衰期为8年,而白人的为17年(P<0.001)。种族差异在年轻人中最为明显,16至30岁的黑人和白人在3年时相差15%-20%。儿科和老年黑人患者的3年移植存活率与白人相似。抗淋巴细胞球蛋白或OKT3预防措施使黑人1年时的移植存活率提高了2%,2年时提高了5%,但半衰期仍为5.6年。与美国的这些发现不同,在加拿大接受移植的63名黑人的短期和长期移植存活率与白人相同,这表明医疗保健系统和社会经济因素具有重要的长期影响。除了改善黑人获得医疗保健的机会和改善HLA分型外,还需要更多黑人供体为等待移植的黑人提供配型更好的移植。